|Articles|May 9, 2018

The Rise and Role of Consumerism in Specialty Pharma

The pharmaceutical industry needs to be paying more attention to consumer purchase habits.

Albert Thigpen, president and chief operating officer of CastiaRx, talks about consumer purchase habits and how the pharmaceutical industry needs to be paying more attention to this detail. His remarks come after a seminar at Asembia’s Specialty Pharmacy Summit in Las Vegas.

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Trending on PharmExec

The Rise and Role of Consumerism in Specialty Pharma

Related Content

The Structural Problems Causing the Pharma and Biotech Industries’ Compliance Failures

Why FDA is Sending an Increased Number of Drug Warning Letters

How Regulators and the Industry Can Work Together to Improve the US Pharma Ecosystem

What Steps US Regulators Are Taking to Promote Domestic Investment

When Foreign Investments in Pharma and Biotech Become a National Security Concern

Trending on PharmExec

Legal Risk in a Rumored AstraZeneca-BMS Deal: Q&A with Ron Lanton

FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma

Your Questions Answered: The Biggest Pharma Stories of the Week of August 3-7, 2026

Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million

The Merger Paradox: Why Transformational Mergers Create Extraordinary Value and Frequently Fail